• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

出生缺陷研究与预防的下一步:评估孕期暴露的出生缺陷研究(BD-STEPS)。

Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).

作者信息

Tinker Sarah C, Carmichael Suzan L, Anderka Marlene, Browne Marilyn L, Caspers Conway Kristin M, Meyer Robert E, Nembhard Wendy N, Olney Richard S, Reefhuis Jennita

机构信息

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University, Stanford, California.

出版信息

Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):733-40. doi: 10.1002/bdra.23373. Epub 2015 Apr 6.

DOI:10.1002/bdra.23373
PMID:25846741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4537667/
Abstract

BACKGROUND

The Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) is a population-based, multi-Center case-control study of modifiable risk factors for selected birth defects in the United States. BD-STEPS is the second major research effort of the Centers for Birth Defects Research and Prevention, which extends and expands the initial research effort, the National Birth Defects Prevention Study (NBDPS).

METHODS

BD-STEPS focuses on 17 categories of structural birth defects selected based on severity, prevalence, consistent ascertainment, and previous findings that warrant additional research. Cases are identified through existing birth defects surveillance programs; controls are from vital records or birth hospital logs from the same catchment area. BD-STEPS uses a standardized computer-assisted telephone interview to collect information from case and control mothers on topics including demographics, health conditions, and medication use. Following the maternal interview, selected Centers request permission to sample residual newborn screening blood spots from state repositories for genetic analyses. New components planned for BD-STEPS include linkages with external datasets and use of online questionnaires to collect in-depth information on selected exposures.

RESULTS

BD-STEPS extends NBDPS by continuing to collect data on many exposures that were assessed in NBDPS, allowing data from both studies to be combined and providing an unprecedented sample size to analyze rare exposures. BD-STEPS expands upon NBDPS by collecting more detailed information on existing exposures as well as new exposures.

CONCLUSION

The goal of BD-STEPS is to provide women and healthcare providers with information they need to make decisions to promote the healthiest pregnancy possible.

摘要

背景

出生缺陷研究以评估孕期暴露情况(BD-STEPS)是一项基于人群的多中心病例对照研究,旨在探究美国特定出生缺陷的可改变风险因素。BD-STEPS是出生缺陷研究与预防中心的第二项重大研究工作,它扩展并延伸了最初的研究工作——国家出生缺陷预防研究(NBDPS)。

方法

BD-STEPS聚焦于17类结构性出生缺陷,这些缺陷是根据严重程度、患病率、一致的确诊情况以及先前需要进一步研究的结果来选定的。病例通过现有的出生缺陷监测项目进行识别;对照则来自同一集水区的人口动态记录或出生医院日志。BD-STEPS使用标准化的计算机辅助电话访谈,从病例和对照母亲那里收集有关人口统计学、健康状况和药物使用等主题的信息。在对母亲进行访谈之后,选定的中心会请求从州储存库中抽取残留的新生儿筛查血斑样本进行基因分析。BD-STEPS计划新增的内容包括与外部数据集建立联系,以及使用在线问卷来收集有关选定暴露的深入信息。

结果

BD-STEPS通过继续收集NBDPS中评估的许多暴露数据,对NBDPS进行了扩展,使得两项研究的数据能够合并,并提供了前所未有的样本量来分析罕见暴露。BD-STEPS通过收集有关现有暴露以及新暴露的更详细信息,对NBDPS进行了拓展。

结论

BD-STEPS的目标是为女性和医疗保健提供者提供他们做出决策所需的信息,以促进尽可能健康的孕期。

相似文献

1
Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).出生缺陷研究与预防的下一步:评估孕期暴露的出生缺陷研究(BD-STEPS)。
Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):733-40. doi: 10.1002/bdra.23373. Epub 2015 Apr 6.
2
The National Birth Defects Prevention Study.国家出生缺陷预防研究
Public Health Rep. 2001;116 Suppl 1(Suppl 1):32-40. doi: 10.1093/phr/116.S1.32.
3
Guidelines for case classification for the National Birth Defects Prevention Study.国家出生缺陷预防研究病例分类指南。
Birth Defects Res A Clin Mol Teratol. 2003 Mar;67(3):193-201. doi: 10.1002/bdra.10012.
4
The National Birth Defects Prevention Study: A review of the methods.国家出生缺陷预防研究:方法综述
Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):656-69. doi: 10.1002/bdra.23384. Epub 2015 Jun 2.
5
Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014-2018).母体环苯扎林暴露与出生缺陷风险:全国出生缺陷预防研究(1997-2011 年)和妊娠暴露评估出生缺陷研究(2014-2018 年)。
Pharmacoepidemiol Drug Saf. 2023 Aug;32(8):855-862. doi: 10.1002/pds.5619. Epub 2023 Mar 29.
6
Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures.国家出生缺陷预防研究中的母体暴露:特定暴露的时间趋势
Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):703-12. doi: 10.1002/bdra.23377. Epub 2015 Apr 17.
7
Preventing birth defects: The value of the NBDPS case-control approach.预防出生缺陷:全国出生缺陷预防研究病例对照研究方法的价值
Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):670-9. doi: 10.1002/bdra.23404. Epub 2015 Jul 14.
8
Findings from the National Birth Defects Prevention Study: Interpretation and translation for the clinician.国家出生缺陷预防研究的结果:临床医生的解读与翻译
Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):721-8. doi: 10.1002/bdra.23394. Epub 2015 Jun 25.
9
Thyroid Medication Use and Birth Defects in the National Birth Defects Prevention Study.甲状腺药物使用与出生缺陷:全国出生缺陷预防研究。
Birth Defects Res. 2017 Nov 1;109(18):1471-1481. doi: 10.1002/bdr2.1095. Epub 2017 Jul 31.
10
Public Health Practice of Population-Based Birth Defects Surveillance Programs in the United States.美国基于人群的出生缺陷监测项目的公共卫生实践
J Public Health Manag Pract. 2016 May-Jun;22(3):E1-8. doi: 10.1097/PHH.0000000000000221.

引用本文的文献

1
Maternal physical activity, sitting, and risk of non-cardiac birth defects.母体身体活动、久坐与非心脏性出生缺陷风险。
Pediatr Res. 2024 Jan;95(1):334-341. doi: 10.1038/s41390-023-02768-y. Epub 2023 Aug 5.
2
The Awareness of Females About Risk Factors That Lead to Having a Baby With Congenital Heart Disease in Taif, Saudi Arabia.沙特阿拉伯塔伊夫女性对导致生育先天性心脏病患儿的风险因素的认知
Cureus. 2023 Jun 22;15(6):e40800. doi: 10.7759/cureus.40800. eCollection 2023 Jun.
3
Toxicology knowledge graph for structural birth defects.用于结构性出生缺陷的毒理学知识图谱。
Commun Med (Lond). 2023 Jul 17;3(1):98. doi: 10.1038/s43856-023-00329-2.
4
Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997-2018.美国 1997-2018 年妊娠早期处方药使用模式。
Clin Pharmacol Ther. 2023 Oct;114(4):836-844. doi: 10.1002/cpt.2981. Epub 2023 Jul 11.
5
Maternal exposure to zolpidem and risk of specific birth defects.母体暴露于唑吡坦与特定出生缺陷风险。
J Sleep Res. 2024 Feb;33(1):e13958. doi: 10.1111/jsr.13958. Epub 2023 Jun 2.
6
Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014-2018).母体环苯扎林暴露与出生缺陷风险:全国出生缺陷预防研究(1997-2011 年)和妊娠暴露评估出生缺陷研究(2014-2018 年)。
Pharmacoepidemiol Drug Saf. 2023 Aug;32(8):855-862. doi: 10.1002/pds.5619. Epub 2023 Mar 29.
7
COVID-19 in pregnancy-what study designs can we use to assess the risk of congenital anomalies in relation to COVID-19 disease, treatment and vaccination?妊娠期 COVID-19-我们可以使用哪些研究设计来评估与 COVID-19 疾病、治疗和疫苗接种相关的先天性畸形风险?
Paediatr Perinat Epidemiol. 2022 Jul;36(4):493-507. doi: 10.1111/ppe.12840. Epub 2022 Mar 2.
8
Correlates of knowledge of genetic diseases and congenital anomalies among pregnant women attending antenatal clinics in Lagos, South-West Nigeria.尼日利亚拉各斯西南部产前诊所孕妇对遗传性疾病和先天性异常知识的相关性。
Pan Afr Med J. 2021 Mar 28;38:310. doi: 10.11604/pamj.2021.38.310.26636. eCollection 2021.
9
Testing and Validating Semi-automated Approaches to the Occupational Exposure Assessment of Polycyclic Aromatic Hydrocarbons.测试和验证多环芳烃职业暴露评估的半自动方法。
Ann Work Expo Health. 2021 Jul 3;65(6):682-693. doi: 10.1093/annweh/wxab002.
10
The safety of asthma medications during pregnancy and lactation: Clinical management and research priorities.哮喘药物在妊娠和哺乳期的安全性:临床管理和研究重点。
J Allergy Clin Immunol. 2021 Jun;147(6):2009-2020. doi: 10.1016/j.jaci.2021.02.037. Epub 2021 Mar 10.

本文引用的文献

1
Validating assisted reproductive technology self-report.验证辅助生殖技术自我报告。
Epidemiology. 2014 Sep;25(5):773-5. doi: 10.1097/EDE.0000000000000153.
2
Maternal exposure to criteria air pollutants and congenital heart defects in offspring: results from the national birth defects prevention study.母亲暴露于标准空气污染物与后代先天性心脏病:国家出生缺陷预防研究的结果
Environ Health Perspect. 2014 Aug;122(8):863-72. doi: 10.1289/ehp.1307289. Epub 2014 Apr 11.
3
Cancer and pregnancy: an overview for obstetricians and gynecologists.癌症与妊娠:妇产科医生概述
Am J Obstet Gynecol. 2014 Jul;211(1):7-14. doi: 10.1016/j.ajog.2013.12.002. Epub 2013 Dec 4.
4
Prenatal nitrate intake from drinking water and selected birth defects in offspring of participants in the national birth defects prevention study.饮用水中硝酸盐摄入与参与国家出生缺陷预防研究的参与者后代中选定的出生缺陷。
Environ Health Perspect. 2013 Sep;121(9):1083-9. doi: 10.1289/ehp.1206249. Epub 2013 Jun 14.
5
Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples.细胞因子检测:血液和组织样本的制备和处理评估。
Methods. 2013 May 15;61(1):10-7. doi: 10.1016/j.ymeth.2013.04.005. Epub 2013 Apr 19.
6
Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.1997 - 2007年全国出生缺陷预防研究:妊娠早期报告使用文拉法辛与出生缺陷之间的关联
Birth Defects Res A Clin Mol Teratol. 2013 Jan;97(1):28-35. doi: 10.1002/bdra.23096. Epub 2012 Dec 26.
7
Self-reported maternal smoking during pregnancy by source in Utah, 2003-2007.2003 - 2007年犹他州按来源统计的孕期自我报告的孕妇吸烟情况。
Birth Defects Res A Clin Mol Teratol. 2012 Dec;94(12):996-1003. doi: 10.1002/bdra.23058. Epub 2012 Jul 23.
8
Major, non-chromosomal, birth defects and maternal physical activity: a systematic review.主要的非染色体出生缺陷与母亲身体活动:一项系统综述
Birth Defects Res A Clin Mol Teratol. 2012 Jul;94(7):521-31. doi: 10.1002/bdra.23017. Epub 2012 May 25.
9
Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010.2001 - 2010年美国哮喘患病率、医疗保健利用情况及死亡率的趋势
NCHS Data Brief. 2012 May(94):1-8.
10
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.美国成年人肥胖率及体重指数分布的趋势:1999-2010 年。
JAMA. 2012 Feb 1;307(5):491-7. doi: 10.1001/jama.2012.39. Epub 2012 Jan 17.